Core Viewpoint - The stock of Renmin Tongtai (600829) experienced significant price fluctuations, with a cumulative increase of over 20% in three consecutive trading days, triggering abnormal trading conditions as per Shanghai Stock Exchange regulations [1] Company Summary - Renmin Tongtai announced that it conducted a self-examination and confirmed with its controlling shareholder, Harbin Pharmaceutical Group Co., Ltd., that there are no undisclosed significant matters or important information [1] - The company primarily engages in pharmaceutical wholesale, retail, logistics services, and medical services, with no major changes in its core business operations [1] Market Performance - As of the close on November 11, Renmin Tongtai's stock price was 11.36 yuan per share, reflecting a daily increase of 9.97%, with a total market capitalization of 6.588 billion yuan [1]
股价大涨,人民同泰发股票交易异常波动公告